Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2000
09/14/2000CA2362422A1 Polynucleotides and proteins encoded thereby
09/14/2000CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization
09/13/2000WO2001019181A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine.
09/13/2000EP1035209A1 Stable recombinant influenza viruses free of helper viruses
09/13/2000EP1035208A1 VARIANT loxP SEQUENCES AND APPLICATION OF THE SAME
09/13/2000EP1035206A1 Astaxanthin Synthetase
09/13/2000EP1035205A1 Non-spreading pestivirus
09/13/2000EP1035203A1 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants
09/13/2000EP1035202A2 A cloning method for DNA fragments using arbitrarily primed PCR
09/13/2000EP1035133A2 Fusion proteins comprising carriers that can induce a dual immune response
09/13/2000EP1035132A1 Monoclonal antibody inducing apoptosis
09/13/2000EP1034785A2 Hepatitis C virus diagnostics and vaccines
09/13/2000EP1034309A2 Method for producing complex dna methylation fingerprints
09/13/2000EP1034308A1 Method of generating conditionally expressed mutant cells using expressible antisense sequences
09/13/2000EP1034296A1 ribH POLYPEPTIDES AND POLYNUCLEOTIDES
09/13/2000EP1034288A1 Methods of isolating and using cd7+cd34-lin-hematopoietic cells
09/13/2000EP1034285A2 Isolation and characterization of plant regulatory sequences
09/13/2000EP1034273A1 Histamine and serotonin binding molecules
09/13/2000EP1034272A1 A cDNA ENCODING C6 $g(b)-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
09/13/2000EP1034271A2 Transgenic non-human mammals with an oncogenic mutant of raf gene 1
09/13/2000EP1034269A1 An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
09/13/2000EP1034268A1 G-protein coupled receptors and uses therefor
09/13/2000EP1034267A1 Compositions and methods for inducing gene expression
09/13/2000EP1034266A1 Method for preparing adenovirus vectors, vectors so prepared, and uses thereof
09/13/2000EP1034265A1 Human cdc10 homolog
09/13/2000EP1034264A1 Splice variants for human 5-ht 4? serotonin receptor and their applications, in particular for screening
09/13/2000EP1034258A2 Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell
09/13/2000EP1034255A1 Lineage restricted glial precursors from the central nervous system
09/13/2000EP1034187A1 $i(IN VITRO) AND $i(IN VIVO) GROWTH-PROMOTING PROTEINS AND PEPTIDES FOR KIDNEY EPITHELIAL CELLS
09/13/2000EP1034185A2 Pharmaceutical compositions containing the long pentraxin ptx3
09/13/2000EP1034003A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
09/13/2000EP1034000A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
09/13/2000EP1033953A1 Method of cross-linking keratin-based films, sheets, and bulk materials
09/13/2000EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof
09/13/2000EP0938557B1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit
09/13/2000EP0832207B1 A method for identification of biologically active peptides and nucleic acids
09/13/2000EP0772624B1 Interleukin-15
09/13/2000EP0733059B1 Compounds and methods for site-directed mutations in eukaryotic cells
09/13/2000EP0514488B1 Retinoid receptor compositions and methods
09/13/2000CN1266101A Astaxanthin synthetic enzyme
09/13/2000CN1056410C Iris tissue culture medium composition
09/13/2000CN1056409C Iris tissue culture method
09/13/2000CN1056408C Tissue culture method using polypropylene film bag as tissue culture packing vessel
09/13/2000CA2381124A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine
09/12/2000US6118050 Nucleic acid which encodes polypeptide of defined amino acid sequence; transgenic cells and seeds; for screening herbicides
09/12/2000US6118049 Synthetic hybrid tomato E4/E8 plant promoter
09/12/2000US6118047 Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
09/12/2000US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents
09/12/2000US6117985 Negative selection process for enriching and recovering non-hematopoietic cells by reacting sample with antibodies which bind glycophorin a, cd2, cd14, cd16, cd38, cd45 and cd66b; removing bound cells; recovering tumor cells
09/12/2000US6117981 Hybridomas for lung cancer marker and monoclonal antibodies thereof
09/12/2000US6117978 Protein having at least 63% identity to human protein having defined amino acid sequence; for diagnosis and therapy of alzheimer's disease; drug screening
09/12/2000US6117680 Compositions and methods for regulation of transcription
09/12/2000US6117678 Method for determining maturity of conifer somatic embryos
09/12/2000US6117675 Retinal stem cells
09/12/2000US6117674 Pathogen propagation in cultured three-dimensional tissue mass
09/12/2000US6117667 Method for producing an adapted virus population from an African green monkey kidney cell line
09/12/2000US6117665 DNA molecules coding for debranching enzymes derived from plants
09/12/2000US6117654 Nucleotide sequence coding antiinflammatroy proteins; antiarthritic agents; antiinflammatory agents; bronchodilator agents
09/12/2000US6117653 Hepatitis B surface antigen vaccine
09/12/2000US6117652 Production of proteins by cell culture
09/12/2000US6117650 Testing sample for defects heart muscle activity; coat well with nutrients, plate muscle cells, culture cells, insert test sample into culture, culture cells, monitor adjustment in cell size and release of atrial natriuretic protein
09/12/2000US6117639 Screening for enzyme inhibitors against proteases, determining inhibitory activity; novel transcriptional assay using DNA molecules encoding the fusion protein substrates; Hepatitis C Virus NS3 protease or HIV aspartyl protease
09/12/2000US6117425 Supplemented and unsupplemented tissue sealants, method of their production and use
09/12/2000US6117424 Compositions of mononuclear phagocytes useful for promoting axonal regeneration
09/12/2000CA1341097C Factor viii binding domain of von willebrand factor
09/12/2000CA1341095C Cdna coding for the human von willebrand factor, plasmids or phages with such a cdna coding or fragments thereof respectively, micro-organisms and animal or human cell which contain such plasmids or phages, preparation of proteins by the cultivation of the above mentioned hosts, the obtained proteins and pharmaceutical compositions containing a biologically
09/08/2000WO2000052188A1 Packaging cells for retroviral vectors
09/08/2000WO2000052187A2 Enhanced system for construction of adenovirus vectors
09/08/2000WO2000052186A1 Means and methods for fibroblast-like or macrophage-like cell transduction
09/08/2000WO2000052180A1 Methods for generating and screening novel metabolic pathways
09/08/2000WO2000052178A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
09/08/2000WO2000052163A1 Cloning of cdna of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer
09/08/2000WO2000052143A2 The isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
09/08/2000WO2000052142A2 Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation
09/08/2000WO2000052137A2 Plant ligand-gated ion channels
09/08/2000WO2000052135A2 Engineering intracellular sialylation pathways
09/08/2000WO2000052056A2 Anti-plasmodium compositions and methods of use
09/08/2000WO2000052053A1 Antibodies against phosphomannan that are protective against candidiasis
09/08/2000WO2000052046A1 Immunomodulating glycopeptide
09/08/2000WO2000052030A1 Rflat-1: a transcription factor that activates rantes gene expression
09/08/2000WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b)
09/08/2000WO2000052022A1 Secreted proteins and nucleic acids encoding them
09/08/2000WO2000051629A1 Preparations stabilized over long time
09/08/2000WO2000051527A1 In vitro production of transplantable cartilage tissue
09/08/2000WO2000051432A1 Vaccines and gene therapy compositions and methods of making and using the same
09/08/2000WO2000034329A3 Differentiation signal
09/08/2000WO2000029583A3 Immunoglobulin superfamily proteins
09/08/2000WO2000023573A3 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies
09/08/2000WO2000018940A9 Plants and plants cells encoding the wild type cop1 gene and the coil domain thereof
09/08/2000WO2000018212A9 Platelet-derived growth factor c, dna coding therefor, and uses thereof
09/08/2000WO2000015853A9 Recombinant newcastle disease virus rna expression systems and vaccines
09/08/2000WO2000014205A9 Methods for generating high titer helper-free preparations of released recombinant aav vectors
09/08/2000WO2000013651A3 Luciferase reporter bioassay of parathyroid hormone compounds
09/08/2000WO2000012720A3 Elongase genes and uses thereof
09/08/2000WO2000012702A3 Human genes differentially expressed in colorectal cancer
09/08/2000WO2000012546A9 MAMMALIAN elk POTASSIUM CHANNEL GENES
09/08/2000WO2000011144A3 Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof
09/08/2000WO2000009709A3 Proteases and associated proteins
09/08/2000WO2000009697A3 Pesticidal toxins and genes from bacillus laterosporus strains
09/08/2000WO2000000604A9 Methods and compositions for modulating spermatogenesis